Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of meropenem coadministration and APEH polymorphism on valproic acid pharmacokinetics
ChiCTR-IPR-15007444Phase 4Recruiting
- Sponsor
- Central South University
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of valproic acid and meropenem in epilepsy (4 arms), sponsored by Central South University. Primary endpoints: Plasma valproic acid concentration, Plasma valproate-glucuronide concentration and 2 more. Started Jan 2015; status: recruiting.
02
Drugs
valproic acidmeropenem
03
Conditions
epilepsy
Beyond the preview
Go deeper on ChiCTR-IPR-15007444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007444.